Point32Health will dramatically change how and when it pays for Zepbound — the insurer’s preferred GLP-1 weight-loss drug— when used to treat overweight or obesity.

The strategy of rewiring the brain's stress response is rooted in two pieces of scientific literature. One is biochemical. All eight chemicals associated with obesity increase appetite or promote weight gain in stress. These chemicals are: cortisol, dopamine, serotonin, insulin, ghrelin, PYY, leptin, and GLP-1.

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had come to rely on compounded versions is increasingly uncertain.

The Ozempic maker and its peers are setting their sights on oral obesity medications to diversify their portfolios and remain competitive.

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers.

Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus."

Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds amid rising global obesity rates.

In fact, you may have gotten more than a few targeted ads on social media from telehealth platforms selling these cheaper GLP-1 (glucagon-like peptide 1) meds at lower doses than the originals. But can microdosing a GLP-1 really help you lose weight,